The Department of Translational Hematology & Oncology Research conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.
More About UsThe Li Lily Wang lab studies how immune checkpoint proteins regulate anti-tumor immune responses.
Learn MoreThe Yogen Saunthararajah lab studies how to selectively target and eliminate cancer cells without harming healthy cells.
Learn MoreThe researchers demonstrate how vancomycin alters staph evolution, and offer a predictive tool to guide future antibiotic decisions.
Cleveland Clinic researchers show that radiation response in endometrial cancer is impacted by p53 gene mutations, and boost effectiveness using combination therapy.
Genomic model shows promise in tailoring radiation doses, potentially reducing side effects without compromising cure rates.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Translational Hematology & Oncology Research.
View Careers